U.S. insulin costs per patient nearly doubled from 2012 to 2016, study finds
The cost of insulin for treating Type 1 diabetes in the United States nearly doubled over a recent five-year period, underscoring a national outcry over rising drug prices, according to a new analysis.
A patient with Type 1 diabetes incurred annual insulin costs of $5,705, on average, in 2016. The average cost was roughly half that, at $2,864 per patient, in 2012, according to a report released on Tuesday by the nonprofit Health Care Cost Institute.
The figures represent the combined amount paid by a patient and their health plan for the medicine and do not reflect rebates paid at a later date.
(Score: 1) by Tokolosh on Wednesday January 23 2019, @04:32PM
All the debate and politics is about who is going to be forced to pay the inflated price. How can we shift the burden to someone else? But addressing why the price is so high in the first place... nothing!
Rising prices also mean that there is little incentive for providers and suppliers to do something about rising costs.